[16] [18] There is insufficient evidence to determine the risk of adverse outcomes in human pregnancies, and thus, use during pregnancy should be guided by clinical judgment and individual risk assessment
503A pharmacies are traditional, patient-specific compounding pharmacies
The medication is sometimes used off-label for weight management
For patients with severe symptoms, treatment starts with 1000 mcg injected intramuscularly once daily for 7 days, then the frequency can vary to 1-3 times weekly for 4-8 weeks
Tracking injection locations in a calendar or patient app helps maintain compliance and prevents accidental reinjection into already-used sites
References Okamoto A, Yokokawa H, Nagamine T, Fukuda H, Hisaoka T, Naito T